中國北大荒(00039.HK)指疫情對營業額造成重大不利影響
中國北大荒(00039.HK)公布,疫情已對集團的營業額造成重大不利影響,原因是疫情及公共衛生措施造成人力資源瓶頸所致,以及因應全球範圍的供應鏈均面臨壓力,預期下行趨勢會在一定程度上延續至今年上半年的餘下時間。
公司指,至去年底,有4.38億元違約款項,已實施以下措施以解決上述還款問題,包括透過各項成本控制措施,擬提升其經營業績及現金流量,且將專注於現有業務;成功向中國一間銀行獲得新銀行融資4,000萬元人民幣;近期已與違約可換股債券之可換股債券持有人之一名代理簽訂延期協議,延展違約可換股債券之到期日至今年底;為海鮮美食城第一期之物業預售制定預算及佈局其業務規劃;致力物色投資者及安排集資活動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.